Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID)
jRCT1030210488Active, not recruiting
- Sponsor
- Regeneron Pharmaceuticals
- Start
- Mar 2020
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
01
Overview
Open-label, single-arm trial of dupilumab in asthma, sponsored by Regeneron Pharmaceuticals. Primary endpoints: Patient demographics and Baseline characteristics. Started Mar 2020; status: active, not recruiting.
02
Drugs
03
Conditions
asthma
Beyond the preview
Go deeper on jRCT1030210488.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1030210488.